A transcriptome–metabolome analysis of blood from breast cancer patients with obesity revealed more than 180 differentially expressed genes and nearly 100 metabolites; notably, OLFM4 expression was markedly elevated in the obese subgroup [23]. Here, OLFM4 is linked to breast carcinoma.